Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yongli Yu

Showing results (71-80 of 108) with videos related to

Pageof 11
Sort By:
Journal of Immunological Methods|September 18, 2012
Recombinant mycobacterial HSP65 in combination with incomplete Freund's adjuvant induced rat arthritis comparable with that induced by complete Freund's adjuvantLei Zhou, Yongli Yu, Liang Chen, et al.
Applied Microbiology and Biotechnology|May 31, 2020
Diversity of locally produced IFN-α subtypes in human nasopharyngeal epithelial cells and mouse lung tissues during influenza virus infectionLei Yang, Shengnan Wang, Ying Wang, et al.
Applied Microbiology and Biotechnology|June 26, 2019
A LAG3-interfering oligonucleotide acts as an adjuvant to enhance the antibody responses induced by recombinant protein vaccines and inactivated influenza virus vaccinesZhiqin Li, Yilan Song, Cuiyun Cui, et al.
ACS Applied Materials & Interfaces|June 21, 2021
Simple Strategy for Synthesizing LiNi<sub>0.8</sub>Co<sub>0.15</sub>Al<sub>0.05</sub>O<sub>2</sub> Using CoAl-LDH Nanosheet-Coated Ni(OH)<sub>2</sub> as the Precursor: Dual Effects of the Buffer Layer and Synergistic DiffusionPeng Xiao, Yu Cao, Wenhao Li, et al.
Cancer Biotherapy & Radiopharmaceuticals|April 28, 2012
Recombinant hepatitis B virus surface antigen formulated with B-type CpG oligodeoxynucleotide induces therapeutic immunity against hepatitis B virus surface antigen-expressing liver cancer cells in miceXiaojing Zhou, Hongfei Wei, Peng Sun, et al.
Scientific Reports|December 24, 2025
Pre-activation timing determines influenza severity and viral pathogenicity via STING InhibitionTong Zhu, Mengru Zhu, Feiyu Lu, et al.
Iscience|April 23, 2024
The trogocytosis of neutrophils on initial transplanted tumor in miceMengru Zhu, Shengnan Wang, Kuo Qu, et al.
Molecular Immunology|February 10, 2009
Human microsatellite DNA mimicking oligodeoxynucleotides down-regulate TLR9-dependent and -independent activation of human immune cellsDali Hu, Xuejin Su, Ran Sun, et al.
Journal of Leukocyte Biology|August 15, 2020
TGF-β2 interfering oligonucleotides used as adjuvants for microbial vaccinesLiqun Tu, Xiaomeng Sun, Lei Yang, et al.
International Immunopharmacology|May 19, 2012
MF59 formulated with CpG ODN as a potent adjuvant of recombinant HSP65-MUC1 for inducing anti-MUC1+ tumor immunity in miceMing Yang, Youyou Yan, Mingli Fang, et al.
Pageof 11

Showing results (71-80 of 108) with videos related to

Sort By:
Pageof 11
Journal of Immunological Methods|September 18, 2012
Recombinant mycobacterial HSP65 in combination with incomplete Freund's adjuvant induced rat arthritis comparable with that induced by complete Freund's adjuvantLei Zhou, Yongli Yu, Liang Chen, et al.
Applied Microbiology and Biotechnology|May 31, 2020
Diversity of locally produced IFN-α subtypes in human nasopharyngeal epithelial cells and mouse lung tissues during influenza virus infectionLei Yang, Shengnan Wang, Ying Wang, et al.
Applied Microbiology and Biotechnology|June 26, 2019
A LAG3-interfering oligonucleotide acts as an adjuvant to enhance the antibody responses induced by recombinant protein vaccines and inactivated influenza virus vaccinesZhiqin Li, Yilan Song, Cuiyun Cui, et al.
ACS Applied Materials & Interfaces|June 21, 2021
Simple Strategy for Synthesizing LiNi<sub>0.8</sub>Co<sub>0.15</sub>Al<sub>0.05</sub>O<sub>2</sub> Using CoAl-LDH Nanosheet-Coated Ni(OH)<sub>2</sub> as the Precursor: Dual Effects of the Buffer Layer and Synergistic DiffusionPeng Xiao, Yu Cao, Wenhao Li, et al.
Cancer Biotherapy & Radiopharmaceuticals|April 28, 2012
Recombinant hepatitis B virus surface antigen formulated with B-type CpG oligodeoxynucleotide induces therapeutic immunity against hepatitis B virus surface antigen-expressing liver cancer cells in miceXiaojing Zhou, Hongfei Wei, Peng Sun, et al.
Scientific Reports|December 24, 2025
Pre-activation timing determines influenza severity and viral pathogenicity via STING InhibitionTong Zhu, Mengru Zhu, Feiyu Lu, et al.
Iscience|April 23, 2024
The trogocytosis of neutrophils on initial transplanted tumor in miceMengru Zhu, Shengnan Wang, Kuo Qu, et al.
Molecular Immunology|February 10, 2009
Human microsatellite DNA mimicking oligodeoxynucleotides down-regulate TLR9-dependent and -independent activation of human immune cellsDali Hu, Xuejin Su, Ran Sun, et al.
Journal of Leukocyte Biology|August 15, 2020
TGF-β2 interfering oligonucleotides used as adjuvants for microbial vaccinesLiqun Tu, Xiaomeng Sun, Lei Yang, et al.
International Immunopharmacology|May 19, 2012
MF59 formulated with CpG ODN as a potent adjuvant of recombinant HSP65-MUC1 for inducing anti-MUC1+ tumor immunity in miceMing Yang, Youyou Yan, Mingli Fang, et al.
Pageof 11